anti-Cancer/testis Antigen 1B (CTAG1B) Antikörper

The protein encoded by CTAG1B is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. Zusätzlich bieten wir Ihnen Cancer/testis Antigen 1B Kits (3) und Cancer/testis Antigen 1B Proteine (2) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
CTAG1B 1485 P78358
CTAG1B    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Cancer/testis Antigen 1B Antikörper auf antikoerper-online.de

Showing 10 out of 115 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert WB WB Suggested Anti-CTAG1B AntibodyTitration: 1.0 µg/mL <br /> Positive Control: Jurkat Whole Cell 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Human Kaninchen Unkonjugiert WB WB Suggested Anti-CTAG1B Antibody Titration: 1.0 ug/ml Positive Control: Fetal Stomach 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Lane 1: mouse testis lysates Lane 2: mouse lung lysates probed with Anti CTAG1B/Cancer/testis antigen 1 Polyclonal Antibody, Unconjugated (ABIN1385261) at 1:200 in 4 °C. Followed by conjugation to secondary antibody at 1:3000 90min in 37 °C. Predicted band 18kD. Observed band size: 18kD. 100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$295.90
Details
Human Ziege Unkonjugiert ELISA, WB   100 μg Anmelden zum Anzeigen 6 bis 7 Tage
$326.89
Details
Human Maus Unkonjugiert IF, IHC (p), WB 100 μL Anmelden zum Anzeigen 7 bis 9 Tage
$493.17
Details
Human Maus Unkonjugiert IF, WB 100 μL Anmelden zum Anzeigen 7 bis 9 Tage
$493.17
Details
Human Maus Unkonjugiert WB 100 μL Anmelden zum Anzeigen 7 bis 9 Tage
$493.17
Details
Human Maus Unkonjugiert IHC (p), WB 100 μL Anmelden zum Anzeigen 7 bis 9 Tage
$493.17
Details
Human Maus Unkonjugiert IF, WB Anti-CTAG1B mouse monoclonal antibody (ABIN2452329) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTAG1B (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 µg per lane) were separated by SDS-PAGE and immunoblotted with anti-CTAG1B. 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$423.50
Details
Human Maus Unkonjugiert IF, IHC, WB Immunohistochemical staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-CTAG1B mouse monoclonal antibody. (ABIN2452472, Dilution 1:50) Immunohistochemical staining of paraffin-embedded Carcinoma of kidney tissue using anti-CTAG1Bmouse monoclonal antibody. (ABIN2452472, Dilution 1:50) 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$423.50
Details

CTAG1B Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human , , ,
, ,
,
, , , , , , , , , , , , , , , ,
Monkey


Am meisten referenzierte anti-Cancer/testis Antigen 1B Antikörper

  1. Human Polyclonal CTAG1B Primary Antibody für ELISA, MA - ABIN4265165 : Adams, ONeill, Nonaka, Hardin, Chiriboga, Siu, Cruz, Angiulli, Angiulli, Ritter, Holman, Shapiro, Berman, Berner, Shao, Manches, Pan, Venhaus, Hoffman, Jungbluth, Gnjatic, Old, Pavlick, Bhardwaj: Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)

  2. Human Polyclonal CTAG1B Primary Antibody für ELISA, WB - ABIN570720 : Shan, Lou, Xiao, Zhang, Sun, Gao, Cheng, Wu, Xu, Liu: A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer. in Cancer letters 2012 (PubMed)

Weitere Antikörper gegen Cancer/testis Antigen 1B Interaktionspartner

Human Cancer/testis Antigen 1B (CTAG1B) Interaktionspartner

  1. Results support the potential utility of NY-ESO-1, PRAME (zeige PRAME Antikörper), and MAGEA4 (zeige MAGEA4 Antikörper) as targets for immunotherapy and as ancillary prognostic parameters in synovial sarcomas.

  2. Data suggest that only a small fraction of HLA-A*02:01- (HA)-binding ESO peptides are immunogenic, namely those that have high peptide-binding strength and peptide/HA complex stability. This study involved comparison of in silico-predicted and observed cytotoxic T-lymphocyte recognition of tumor antigen epitopes in melanoma patients and transgenic/knockout mice. (ESO = tumor antigen NY-ESO-1)

  3. These data demonstrate that MAGE (zeige MAGEB10 Antikörper)-A1-, MAGE-A3 (zeige MAGEA3 Antikörper)-, and NY-ESO-1-specific T cells with antigen-specific cytotoxicity can be cultured from healthy donors and patient-derived cells making adoptive immunotherapy with these cytotoxic T lymphocyte feasible.

  4. Comparing the overall expression of CTAs, a decreased expression of all melanoma-associated (zeige ZNF654 Antikörper) antigens (MAGEs) post-treatment and a slightly increased expression of New York esophageal squamous cell carcinoma 1 (NY-ESO-1) was visible. The simultaneous cytoplasmic and nuclear expression of pan (zeige SUPT6H Antikörper)-MAGE (zeige MAGEB10 Antikörper) or MAGE-A3 (zeige MAGEA3 Antikörper)/A4 correlated with reduced treatment-failure-free-survival (TFFS).

  5. MAGE (zeige MAGEB10 Antikörper)-A is more highly expressed than NY-ESO-1 in a majority of human malignancies

  6. These cells were used to target a human lung cancer line that expressed NY-ESO-1.

  7. regulation of NY-ESO-1 processing by the ubiquitin receptors Rpn10 and Rpn13 as a well as by the standard and immunoproteasome is governed by non-canonical ubiquitination on non-lysine sites.

  8. CTAs (MAGE-A4, NY-ESO-1, MAGE-A10) were more likely expressed in patients with squamous cell carcinoma of the lung and when CTAs combined with CD133, they can be better prognostic factors.

  9. Among mesenchymal tumors, myxoid liposarcomas showed the highest positivity for NY-ESO-1 (88%), followed by synovial sarcomas (49%), myxofibrosarcomas (35%), and conventional chondrosarcomas (28%).

  10. High expression of NY-ESO-1 is associated with Triple-Negative Breast Cancer.

Cancer/testis Antigen 1B (CTAG1B) Antigen-Profil

Protein Überblick

The protein encoded by this gene is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. This gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence.

Genbezeichner und Symbole assoziert mit CTAG1B

  • cancer/testis antigen 1B (CTAG1B) Antikörper
  • CT6.1 Antikörper
  • CTAG Antikörper
  • CTAG1 Antikörper
  • ESO1 Antikörper
  • LAGE-2 Antikörper
  • LAGE2B Antikörper
  • NY-ESO-1 Antikörper

Bezeichner auf Proteinebene für CTAG1B

New York esophageal squamous cell carcinoma 1 , autoimmunogenic cancer/testis antigen NY-ESO-1 , cancer antigen 3 , cancer/testis antigen 1 , cancer/testis antigen 6.1 , l antigen family member 2

GENE ID SPEZIES
1485 Homo sapiens
Ausgewählte Anbieter für anti-Cancer/testis Antigen 1B (CTAG1B) Antikörper
Haben Sie etwas anderes gesucht?